Breaking News

Molex Agrees to Purchase Vectura Group

Will combine the strengths of Vectura and Philips Medisize to deliver a broader portfolio of inhalation combination drug devices and solutions.

Author Image

By: Charlie Sternberg

Associate Editor

Molex, a parent to Phillips Medisize, has signed an agreement to purchase Vectura Group Limited, a leader in inhalation drug device design and formulation based in Chippenham, UK, from Vectura Fertin Pharma Inc., a subsidiary of Philip Morris International (PMI).   “Combining the strengths of Phillips Medisize and Vectura will enhance our ability to deliver a broader portfolio of inhalation combination drug devices and solutions to our pharmaceutical customers and support our mission to help p...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters